Cash and Cash Equivalents, at Carrying Value of Semnur Pharmaceuticals, Inc. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary: Semnur Pharmaceuticals, Inc. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
Semnur Pharmaceuticals, Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Dec 2025 was $20,000, a 67% increase year-over-year.
Source SEC data: View on sec.gov

Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)

Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Semnur Pharmaceuticals, Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$20,000	+$8,000	+67%	31 Dec 2025	10-K	27 Feb 2026	2025	FY
Q3 2025	$85,000			30 Sep 2025	10-Q	12 Nov 2025	2025	Q3
Q4 2024	$12,000	-$192,464	-94%	31 Dec 2024	10-K	27 Feb 2026	2025	FY
Q1 2024	$1,013			31 Mar 2024	10-Q	22 May 2024	2024	Q1
Q4 2023	$204,464	-$615,283	-75%	31 Dec 2023	10-Q	22 May 2024	2024	Q1
Q3 2023	$13,460			30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q4 2022	$819,747			31 Dec 2022	10-K	01 Apr 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.